Physician
Dermatology
Dr. Craig L. Leonardi, MD
|
|
Give Review
Craig Leonardi is an expert in the field of Dermatology. He studied medicine at University of Miami Miller School of Medicine. University of Miami Miller School of Medicine has a rank of 45 in research and a 0 in primary care He received awards:"Fellow (FAAD)". Craig Leonardi is also a published doctor. He has 100 publication published. The most recent publication is: [Intensive intravenous chelation in thalassemic patients with iron overload]. Craig Leonardi accepts Medicare payments and is registered with Medicare.gov.
Publications
- A high level of clinical response is associated with improved patient-reported outcomes in Psoriasis: analyses from a phase 2 study in patients treated with ixekizumab.
- Humanized anti-IFN-γ (HuZAF) in the treatment of Psoriasis.
- Safety and efficacy of brodalumab for Psoriasis after 120 weeks of treatment.
- A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque Psoriasis.
- Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe Psoriasis.
- New and emerging therapies in Psoriasis.
- Demography, baseline disease characteristics, and treatment history of patients with Psoriasis enrolled in a multicenter, prospective, disease-based registry (PSOLAR).
- Research gaps in Psoriasis: Opportunities for future studies.
- Integrated safety analysis: Short- and long-term safety profiles of etanercept in patients with Psoriasis.
- Association between biologic therapies for chronic plaque Psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials.
- Guidelines of care for the management of Psoriasis and psoriatic arthritis Section 6. Guidelines of care for the treatment of Psoriasis and psoriatic arthritis: Case-b...
- Efficacy and safety of adalimumab across subgroups of patients with moderate to severe Psoriasis.
- Subgroup analyses of etanercept in pediatric patients with Psoriasis.
- Alefacept for Psoriasis.
- A series of critically challenging case scenarios in moderate to severe Psoriasis: a Delphi consensus approach.
- Persistent CD4+ T Cell depression following combination alefacept and methotrexate therapy.
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: Section 1. Overview of Psoriasis and guidelines of care for the treatment of Psoriasis with...
- Guidelines of care for the management of Psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an empha...
- Adalimumab therapy for moderate to severe Psoriasis: A randomized, controlled phase III trial.
- On multiple courses of alefacept.
- Long-term management of plaque Psoriasis with continuous efalizumab therapy.
- Etanercept monotherapy in patients with Psoriasis: a summary of safety, based on an integrated multistudy database.
- Clinical efficacy of efalizumab in patients with chronic plaque Psoriasis: results from three randomized placebo-controlled Phase III trials: part I.
- Current concepts and review of efalizumab in the treatment of Psoriasis.
- Efalizumab: an overview.
- Overview of Psoriasis: update on current and emerging treatment options.
- Ten Years On: The Impact of Biologics on the Practice of Dermatology.
- Epidermodysplasia verruciformis-associated papillomavirus Infection complicating human immunodeficiency virus disease.
- The antiinflammatory cytokine interleukin-13 is not detectable in the circulation of multiple sclerosis patients and is not inducible by interferon-beta1b treatment, t...
- Childhood neglect and parental care perception in cocaine addicts: relation with psychiatric symptoms and biological correlates.
- Swollen keratinocytes: a histologic marker of unusual human papillomavirus-type Infection and immunosuppression.
- Human papillomavirus and herpes virus DNA are not detected in Benign and malignant prostatic tissue using the polymerase chain reaction.
- Polymerase chain reaction: relevance for dermatopathology.
- Irritated seborrheic keratoses and Benign verrucous acanthomas do not contain papillomavirus DNA.
- Infantile digital fibromatosis: ultrastructural human papillomavirus and Herpes simplex virus DNA observation.
- Trichilemmomas are not associated with human papillomavirus DNA.
- Total ankle arthroplasty in France.
- [Intensive intravenous chelation in thalassemic patients with iron overload].
- [Osteosynthesis of radial head fractures in adults].
- Alopecia areata and presence of cytomegalovirus DNA.
- Hemodialysis-related Lesions of the hand.
- Deoxyspergualin neither counteracts lipopolysaccharide (LPS) or Staphylococcus aureus enterotoxin-B (SEB) induced lethality in mice nor does it modulate the release of...
- Herpes simplex virus DNA in occult Lesions: demonstration by the polymerase chain reaction.
- Seborrheic keratoses from the genital region may contain human papillomavirus DNA.
- The clinical spectrum from classic variCella zoster to zoster sine herpete: the missing link.
- Absence of human papillomavirus Infection in cutaneous lichen planus.
- Role of Mycobacterium paratuberculosis in Crohn's disease: a prospective, controlled study using polymerase chain reaction.
- Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination.
- Human papillomavirus DNA in the dermis of condyloma acuminatum.
- Cutaneous reactions following herpes zoster Infections: report of three cases and a review of the literature.
- Risk factors for relapse after conservative treatment in T1-T2 breast Cancer with one to three positive axillary nodes: results of an observational study.
- Confirmation of early Kaposi's sarcoma by polyclonal antibody to type IV collagen.
- Mosquito salivary gland antigens identified by circulating human antibodies.
- Detection with the polymerase chain reaction of human papillomavirus DNA in condylomata acuminata treated in vitro with liquid nitrogen, trichloroacetic acid, and podo...
- Human papillomavirus type 6 Infection involving cutaneous nongenital sites.
- Basal cell carcinoma of the scrotum. Report of three cases and review of the literature.
- Identification of Mycobacterium tuberculosis DNA in a case of lupus vulgaris.
- Acute papuloSquamous eruption of the extremities demonstrating an isomorphic response. Inverse pityriasis rosea (PR).
- Disseminated Infection with Trichosporon beigelii. Report of a case and review of the cutaneous and histologic manifestations.
- Acrokeratoelastoidosis of Costa.
- Analysis of the polymerase chain reaction in the detection of Herpesvirus DNA from fixed and stained tissue sections.
- Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea).
- Identification of Mycobacterium tuberculosis DNA in five different types of cutaneous Lesions by the polymerase chain reaction.
- Detection of herpes simplex and variCella-zoster infection from cutaneous lesions in different clinical stages with the polymerase chain reaction.
- Comparison of Tzanck smear, viral culture, and DNA diagnostic methods in detection of herpes simplex and variCella-zoster infection.
- Concurrent herpes simplex and variCella-zoster infection in an immunocompromised patient.
- Human papillomavirus screening in pediatric victims of sexual abuse.
- A classification of Psoriasis vulgaris according to phenotype.
- An evaluation of oral ulcers in patients with AIDS and AIDS-related complex.
- A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of ...
- Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque Psoriasis.
- Zosteriform multiple leiomyomas.
- Efalizumab-induced autoimmune pancytopenia.
- European S3-guidelines on the systemic treatment of Psoriasis vulgaris.
- Comparison of clinical and pharmacokinetic profiles of etanercept 25 mg twice weekly and 50 mg once weekly in patients with Psoriasis.
- Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque Psoriasis for up to 96 weeks.
- Diagnosis and treatment of a case of cutaneous cytomegalovirus Infection with a dramatic clinical presentation.
- The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans Cell density in psoriatic plaques.
- Efalizumab: results of a 3-year continuous dosing study for the long-term control of Psoriasis.
- Etanercept: an evolving role in Psoriasis and psoriatic arthritis.
- A transient benign lymph node-based proliferation of T-Cells simulating non-Hodgkin lymphoma in a patient with psoriasis treated with tumor necrosis factor alpha and C...
- Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque Psoriasis.
- Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with Psoriasis: 76-week results from a randomised, double-blind, placebo...
- A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque Psoriasis.
- Efalizumab retreatment in patients with moderate to severe chronic plaque Psoriasis.
- Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque Psoriasis: updated results from an ongoing trial.
- Clinical response in Psoriasis patients discontinued from and then reinitiated on etanercept therapy.
- Etanercept as monotherapy in patients with Psoriasis.
- Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque Psoriasis.
- Efalizumab in the treatment of Psoriasis.
- Extended efalizumab therapy improves chronic plaque Psoriasis: results from a randomized phase III trial.
- Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque Psoriasis.
- The burden of illness associated with Psoriasis: cost of treatment with systemic therapy and phototherapy in the US.
- Treating psoriasis as a T-Cell mediated disease.
- Etanercept and clinical outcomes, fatigue, and depression in Psoriasis: double-blind placebo-controlled randomised phase III trial.
- Clinical response to adalimumab treatment in patients with moderate to severe Psoriasis: double-blind, randomized controlled trial and open-label extension study.
- Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of Acne vulgaris.
- Eruptive papules during efalizumab (anti-CD11a) therapy of Psoriasis vulgaris: a case series.
- A human interleukin-12/23 monoclonal antibody for the treatment of Psoriasis.
Schools
Univ Of Miami Sch Of Med
Jackson Mem HospJackson Health
Procedures Preformed
- Acne Surgery
- Destruction of Benign Skin Lesion
- Destruction of Malignant Skin Lesion
- Excision of Benign Skin Lesion
- View All
Conditions Treated
- Acne
- Actinic Keratosis
- Atopic Dermatitis (Eczema)
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Dermatology
Accepted Insurances
Awards
- Fellow (FAAD)
Education
-
Jackson Memorial Hospital - Jackson Health System -
University of Miami Miller School of Medicine
Drug Facts
| NPI NUMBER | 1477626869 | |
| NPPES Provider LastName | LEONARDI | |
| NPPES Provider FirstName | CRAIG | |
| NPPES Provider ZIPCode | 631171206 | |
| NPPES Provider State | MO | |
| Specialty Description | Dermatology | |
| Total Claim Count | 1157.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1477626869 |
| Last Name Of The Provider | LEONARDI |
| First Name Of The Provider | CRAIG |
| View All |
Similar Doctors
|
|
Dr. Reena Varade, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph M. Duvall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lee S. Portnoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Caroline M. Mann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andras Schaffer, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jaeyoung Yoon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shadmehr Demehri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karl W. Staser, MD |
|
|
Dr. Hugh Dorris, DDS
This Doctor is OpenDoctor Recommended.
|